| __timestamp | Bausch Health Companies Inc. | Johnson & Johnson |
|---|---|---|
| Wednesday, January 1, 2014 | 2026300000 | 21954000000 |
| Thursday, January 1, 2015 | 2682700000 | 21203000000 |
| Friday, January 1, 2016 | 2810000000 | 19945000000 |
| Sunday, January 1, 2017 | 2582000000 | 21420000000 |
| Monday, January 1, 2018 | 2473000000 | 22540000000 |
| Tuesday, January 1, 2019 | 2554000000 | 22178000000 |
| Wednesday, January 1, 2020 | 2367000000 | 22084000000 |
| Friday, January 1, 2021 | 2624000000 | 20118000000 |
| Saturday, January 1, 2022 | 2625000000 | 19046000000 |
| Sunday, January 1, 2023 | 2917000000 | 20112000000 |
| Monday, January 1, 2024 | 21969000000 |
In pursuit of knowledge
In the world of pharmaceuticals, understanding the financial health of companies is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of two industry titans: Johnson & Johnson and Bausch Health Companies Inc., from 2014 to 2023.
Johnson & Johnson, a leader in healthcare, consistently reported SG&A expenses around $21 billion annually. Despite a slight dip in 2022, their expenses remained robust, reflecting their expansive global operations and marketing strategies.
Bausch Health, while smaller, showed a more dynamic trend. Starting at $2 billion in 2014, their SG&A expenses grew by approximately 44% by 2023, indicating aggressive market expansion and strategic investments.
The contrasting trends highlight Johnson & Johnson's stability and Bausch Health's growth trajectory, offering valuable insights for investors and industry analysts alike.
Johnson & Johnson and Merck & Co., Inc.: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Johnson & Johnson vs Alnylam Pharmaceuticals, Inc.
Johnson & Johnson and BioMarin Pharmaceutical Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Johnson & Johnson and Exelixis, Inc.
Who Optimizes SG&A Costs Better? Johnson & Johnson or Jazz Pharmaceuticals plc
Who Generates More Revenue? Johnson & Johnson or Bausch Health Companies Inc.
Breaking Down SG&A Expenses: Walgreens Boots Alliance, Inc. vs Bausch Health Companies Inc.
Cytokinetics, Incorporated vs Bausch Health Companies Inc.: SG&A Expense Trends
Who Optimizes SG&A Costs Better? Apellis Pharmaceuticals, Inc. or Bausch Health Companies Inc.
Bausch Health Companies Inc. vs Iovance Biotherapeutics, Inc.: SG&A Expense Trends
Bausch Health Companies Inc. or HUTCHMED (China) Limited: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Bausch Health Companies Inc. and Galapagos NV